Regulatory role of natural killer T cells in diabetes

Atkinson, 2014, Type 1 diabetes, Lancet, 383, 69, 10.1016/S0140-6736(13)60591-7 Diana, 2013, Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes, Nat Med, 19, 65, 10.1038/nm.3042 Lehuen, 2010, Immune cell crosstalk in type 1 diabetes, Nat Rev Immunol, 10, 501, 10.1038/nri2787 Willcox, 2009, Analysis of islet inflammation in human type 1 diabetes, Clin Exp Immunol, 155, 173, 10.1111/j.1365-2249.2008.03860.x Delovitch, 1997, The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD, Immunity, 7, 727, 10.1016/S1074-7613(00)80392-1 Anderson, 2005, The NOD mouse: a model of immune dysregulation, Annu Rev Immunol, 23, 447, 10.1146/annurev.immunol.23.021704.115643 Zhen, 2012, Alterations of peripheral CD4+CD25+Foxp3+ T regulatory cells in mice with STZ-induced diabetes, Cell Mol Immunol, 9, 75, 10.1038/cmi.2011.37 Mahler, 1999, Clinical review 102: type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment, J Clin Endocrinol Metab, 84, 1165, 10.1210/jcem.84.4.5612 Kahn, 2014, Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future, Lancet, 383, 1068, 10.1016/S0140-6736(13)62154-6 Bendelac, 1997, Mouse CD1-specific NK1 T cells: development, specificity, and function, Annu Rev Immunol, 15, 535, 10.1146/annurev.immunol.15.1.535 Bendelac, 2007, The biology of NKT cells, Annu Rev Immunol, 25, 297, 10.1146/annurev.immunol.25.022106.141711 Simoni, 2013, Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?, Clin Exp Immunol, 171, 8, 10.1111/j.1365-2249.2012.04625.x Kronenberg, 2002, The unconventional lifestyle of NKT cells, Nat Rev Immunol, 2, 557, 10.1038/nri854 Jahng, 2004, Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide, J Exp Med, 199, 947, 10.1084/jem.20031389 Arrenberg, 2010, Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid, Proc Natl Acad Sci U S A, 107, 10984, 10.1073/pnas.1000576107 Treiner, 2003, Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1, Nature, 422, 164, 10.1038/nature01433 Diana, 2009, NKT cells: friend or foe during viral infections?, Eur J Immunol, 39, 3283, 10.1002/eji.200939800 Tupin, 2007, The unique role of natural killer T cells in the response to microorganisms, Nat Rev Microbiol, 5, 405, 10.1038/nrmicro1657 Cohen, 2009, Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity, Adv Immunol, 102, 1, 10.1016/S0065-2776(09)01201-2 Mieza, 1996, Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice, J Immunol, 156, 4035, 10.4049/jimmunol.156.10.4035 Takeda, 1993, J Exp Med, 177, 155, 10.1084/jem.177.1.155 Gombert, 1996, Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse, Eur J Immunol, 26, 2989, 10.1002/eji.1830261226 Hammond, 2001, CD1d-restricted NKT cells: an interstrain comparison, J Immunol, 167, 1164, 10.4049/jimmunol.167.3.1164 Kojo, 2001, Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases, Arthritis Rheum, 44, 1127, 10.1002/1529-0131(200105)44:5<1127::AID-ANR194>3.0.CO;2-W Illés, 2000, Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy, J Immunol, 164, 4375, 10.4049/jimmunol.164.8.4375 Kukreja, 2002, Multiple immuno-regulatory defects in type-1 diabetes, J Clin Invest, 109, 131, 10.1172/JCI0213605 Sumida, 1995, Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis, J Exp Med, 182, 1163, 10.1084/jem.182.4.1163 Van der Vliet, 2001, Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage, Clin Immunol, 100, 144, 10.1006/clim.2001.5060 Kikutani, 1992, The murine autoimmune diabetes model: NOD and related strains, Adv Immunol, 51, 285, 10.1016/S0065-2776(08)60490-3 Godfrey, 1997, Flow cytometric study of T cell development in NOD mice reveals a deficiency in alphabetaTCR+CDR-CD8- thymocytes, J Autoimmun, 10, 279, 10.1006/jaut.1997.0129 Wang, 2001, CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes, J Exp Med, 194, 313, 10.1084/jem.194.3.313 Lehuen, 1998, Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes, J Exp Med, 188, 1831, 10.1084/jem.188.10.1831 Cain, 2006, NKT cells and IFN-gamma establish the regulatory environment for the control of diabetogenic T cells in the nonobese diabetic mouse, J Immunol, 176, 1645, 10.4049/jimmunol.176.3.1645 Beaudoin, 2002, NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells, Immunity, 17, 725, 10.1016/S1074-7613(02)00473-9 Sharif, 2001, Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes, Nat Med, 7, 1057, 10.1038/nm0901-1057 Rapoport, 1993, Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice, J Exp Med, 178, 87, 10.1084/jem.178.1.87 Laloux, 2001, T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen, J Immunol, 166, 3749, 10.4049/jimmunol.166.6.3749 Hammond, 1998, alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10, J Exp Med, 187, 1047, 10.1084/jem.187.7.1047 Laloux, 2002, Phenotypic and functional differences between NKT cells colonizing splanchnic and peripheral lymph nodes, J Immunol Balt, 168, 3251, 10.4049/jimmunol.168.7.3251 Beaudoin, 2014, Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes, Eur J Immunol, 44, 1454, 10.1002/eji.201343910 Falcone, 2004, Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice, J Immunol Balt, 172, 5908, 10.4049/jimmunol.172.10.5908 Ghazarian, 2013, Protection against type 1 diabetes upon Coxsackievirus B4 infection and iNKT-cell stimulation: role of suppressive macrophages, Diabetes, 62, 3785, 10.2337/db12-0958 Chen, 2009, Natural killer cells modulate overt autoimmunity to homeostasis in nonobese diabetic mice after anti-CD3 F(ab')2 antibody treatment through secreting transforming growth factor-β, Am J Pathol, 175, 1086, 10.2353/ajpath.2009.080488 Höglund, 1999, Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes, J Exp Med, 189, 331, 10.1084/jem.189.2.331 Ghazarian, 2013, Prevention or acceleration of type 1 diabetes by viruses, Cell Mol Life Sci, 70, 239, 10.1007/s00018-012-1042-1 Diana, 2011, Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay, J Exp Med, 208, 729, 10.1084/jem.20101692 Chen, 2005, Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes, J Immunol, 174, 1196, 10.4049/jimmunol.174.3.1196 Spolski, 2009, Cytokine mediators of Th17 function, Eur J Immunol, 39, 658, 10.1002/eji.200839066 Happel, 2003, Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection, J Immunol Balt, 170, 4432, 10.4049/jimmunol.170.9.4432 Shibata, 2007, Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production, J Immunol, 178, 4466, 10.4049/jimmunol.178.7.4466 Doisne, 2009, Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions, J Immunol Balt, 183, 2142, 10.4049/jimmunol.0901059 Michel, 2007, Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia, J Exp Med, 204, 995, 10.1084/jem.20061551 Doisne, 2011, Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria, J Immunol Balt, 186, 662, 10.4049/jimmunol.1002725 Simoni, 2011, NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes, Eur J Immunol, 41, 3574, 10.1002/eji.201141751 Ghazarian, 2014, Invariant NKT cell development: focus on NOD mice, Curr Opin Immunol, 27, 83, 10.1016/j.coi.2014.02.004 Li, 2014, Potential role of IL-17-producing iNKT cells in type 1 diabetes, PloS One, 9, e96151, 10.1371/journal.pone.0096151 Esteban, 2003, Genetic control of NKT cell numbers maps to major diabetes and lupus loci, J Immunol Balt, 171, 2873, 10.4049/jimmunol.171.6.2873 Fletcher, 2008, Congenic analysis of the NKT cell control gene Nkt2 implicates the peroxisomal protein Pxmp4, J Immunol Balt, 181, 3400, 10.4049/jimmunol.181.5.3400 Facciotti, 2012, Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus, Nat Immunol, 13, 474, 10.1038/ni.2245 Gumperz, 2002, Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining, J Exp Med, 195, 625, 10.1084/jem.20011786 Montoya, 2007, Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11, Immunology, 122, 1, 10.1111/j.1365-2567.2007.02647.x Lee, 2002, Distinct functional lineages of human V(alpha)24 natural killer T cells, J Exp Med, 195, 637, 10.1084/jem.20011908 Hegde, 2011, Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands, J Autoimmun, 37, 28, 10.1016/j.jaut.2011.03.001 Roman-Gonzalez, 2009, Frequency and function of circulating invariant NKT cells in autoimmune diabetes mellitus and thyroid diseases in Colombian patients, Hum Immunol, 70, 262, 10.1016/j.humimm.2009.01.012 Wilson, 1998, Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes, Nature, 391, 177, 10.1038/34419 Lee, 2002, Testing the NKT cell hypothesis of human IDDM pathogenesis, J Clin Invest, 110, 793, 10.1172/JCI0215832 Kent, 2005, Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells, J Immunol Balt, 175, 4458, 10.4049/jimmunol.175.7.4458 Chang, 2005, Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients, J Exp Med, 201, 1503, 10.1084/jem.20042592 Blumenfeld, 2011, Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice, Clin Exp Immunol, 166, 121, 10.1111/j.1365-2249.2011.04454.x Motohashi, 2006, A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer, Clin Cancer Res, 12, 6079, 10.1158/1078-0432.CCR-06-0114 Giongo, 2011, Toward defining the autoimmune microbiome for type 1 diabetes, ISME J, 5, 82, 10.1038/ismej.2010.92 Brown, 2011, Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes, PloS One, 6, e25792, 10.1371/journal.pone.0025792 Sorini, 2013, Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes, Am J Clin Exp Immunol, 2, 156 Kostic, 2015, The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes, Cell Host Microbe, 17, 260, 10.1016/j.chom.2015.01.001 Loh, 2014, Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine, Mucosal Immunol, 7, 1233, 10.1038/mi.2014.13 Zeissig, 2013, Commensal microbiota and NKT cells in the control of inflammatory diseases at mucosal surfaces, Curr Opin Immunol, 25, 690, 10.1016/j.coi.2013.09.012 Markle, 2013, Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity, Science, 339, 1084, 10.1126/science.1233521 Terabe, 2005, A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance, J Exp Med, 202, 1627, 10.1084/jem.20051381 Duarte, 2004, Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells, J Immunol Balt, 173, 3112, 10.4049/jimmunol.173.5.3112 Subramanian, 2012, NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected], PloS One, 7, e37771, 10.1371/journal.pone.0037771 Kadri, 2012, CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes, J Immunol Balt, 188, 3138, 10.4049/jimmunol.1101390 Mathis, 2013, Immunological goings-on in visceral adipose tissue, Cell Metab, 17, 851, 10.1016/j.cmet.2013.05.008 Tateya, 2013, Recent advances in obesity-induced inflammation and insulin resistance, Front Endocrinol (Lausanne), 4, 93, 10.3389/fendo.2013.00093 Lynch, 2009, Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity, Eur J Immunol, 39, 1893, 10.1002/eji.200939349 Lynch, 2012, Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production, Immunity, 37, 574, 10.1016/j.immuni.2012.06.016 Lynch, 2015, Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue, Nat Immunol, 16, 85, 10.1038/ni.3047 Schipper, 2012, Natural killer T cells in adipose tissue prevent insulin resistance, J Clin Invest, 122, 3343, 10.1172/JCI62739 Ohmura, 2010, Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice, Arterioscler Thromb Vasc Biol, 30, 193, 10.1161/ATVBAHA.109.198614 Mantell, 2011, Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity, PloS One, 6, e19831, 10.1371/journal.pone.0019831